Tham khảo Quản lý bệnh lao

  1. ↑ Sterling T. R., Villarino M. E., Borisov, Chaisson R. E. (2011). “Three months of rifapentine and isoniazid for latent tuberculosis infection”. New England Journal of Medicine 365 (23): 2155–2166. PMID 22150035. doi:10.1056/nejmoa1104875. CS1 maint: Multiple names: authors list (link)
  2. ↑ World Health Organization. Guidelines on the management of latent tuberculosis infection. WHO/HTM/TB/2015.01. Geneva: World Health Organization; 2015.
  3. ↑ Multidrug and extensively drug-resistant TB (M/XDR-TB) Drugs Used in the Treatment of Tuberculosis
  4. ↑ “Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation”. British Medical Journal 2 (4582): 769–82. Tháng 10 năm 1948. PMC 2091872. PMID 18890300. doi:10.1136/bmj.2.4582.769. 
  5. ↑ Wang JY, Hsueh PR, Jan IS và đồng nghiệp (tháng 10 năm 2006). “Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas”. Thorax 61 (10): 903–08. PMC 2104756. PMID 16809417. doi:10.1136/thx.2005.056887. 
  6. ↑ David HL (tháng 11 năm 1970). “Probability Distribution of Drug-Resistant Mutants in Unselected Populations of Mycobacterium tuberculosis”. Applied Microbiology 20 (5): 810–14. PMC 377053. PMID 4991927. 
  7. ↑ British Thoracic Society (tháng 10 năm 1984). “A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond.”. British Journal of Diseases of the Chest 78 (4): 330–36. PMID 6386028. doi:10.1016/0007-0971(84)90165-7. 
  8. ↑ Ormerod LP, Horsfield N; Horsfield (tháng 7 năm 1987). “Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice”. British Journal of Diseases of the Chest 81 (3): 268–71. PMID 3663498. doi:10.1016/0007-0971(87)90160-4. 
  9. ↑ East AFrican/British Medical Research Councils (1986). “Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study”. Tubercle 67 (1): 5–15. PMID 3521015. 
  10. 1 2 3 Elzinga G, Raviglione MC, Maher D; Raviglione; Maher (tháng 3 năm 2004). “Scale up: meeting targets in global tuberculosis control”. Lancet 363 (9411): 814–19. PMID 15016493. doi:10.1016/S0140-6736(04)15698-5. 
  11. ↑ Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA; Catlin; Peterson; Judson; Sbarbaro (tháng 3 năm 1990). “A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen”. Annals of Internal Medicine 112 (6): 407–15. PMID 2106816. doi:10.7326/0003-4819-76-3-112-6-407. 
  12. 1 2 Dye C, Watt CJ, Bleed DM, Williams BG; Watt; Bleed; Williams (2003). “What is the limit to case detection under the DOTS strategy for tuberculosis control?”. Tuberculosis 83 (1–3): 35–43. PMID 12758187. doi:10.1016/S1472-9792(02)00056-2. 
  13. ↑ Grange JM; Zumla A (tháng 6 năm 2002). “The global emergency of tuberculosis: what is the cause?”. The Journal of the Royal Society for the Promotion of Health 122 (2): 78–81. PMID 12134771. doi:10.1177/146642400212200206. 
  14. ↑ Harries AD, Jahn A, Zachariah R, Enarson D; Jahn; Zachariah; Enarson (tháng 6 năm 2008). “Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa”. PLoS Medicine 5 (6): e124. PMC 3280072. PMID 18547138. doi:10.1371/journal.pmed.0050124. 
  15. ↑ Iseman MD (tháng 11 năm 1998). “MDR-TB and the developing world--a problem no longer to be ignored: the WHO announces 'DOTS Plus' strategy”. The International Journal of Tuberculosis and Lung Disease 2 (11): 867. PMID 9848604. 
  16. ↑ Sterling TR, Lehmann HP, Frieden TR; Lehmann; Frieden (tháng 3 năm 2003). “Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis”. BMJ 326 (7389): 574. PMC 151519. PMID 12637401. doi:10.1136/bmj.326.7389.574. 
  17. ↑ Campbell IA, Ormerod LP, Friend JA, Jenkins PA, Prescott RJ; Ormerod; Friend; Jenkins; Prescott (tháng 11 năm 1993). “Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results”. Respiratory Medicine 87 (8): 621–23. PMID 8290746. doi:10.1016/S0954-6111(05)80265-3. 
  18. ↑ Upadhyay SS, Saji MJ, Yau AC; Saji; Yau (tháng 8 năm 1996). “Duration of antituberculosis chemotherapy in conjunction with radical surgery in the management of spinal tuberculosis”. Spine 21 (16): 1898–903. PMID 8875723. doi:10.1097/00007632-199608150-00014. 
  19. ↑ Darbyshire, J.; Darbyshire, J (1999). “Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council Working Party on Tuberculosis of the Spine”. International Orthopaedics 23 (2): 73–81. PMC 3619789. PMID 10422019. doi:10.1007/s002640050311. 
  20. ↑ Parthasarathy R, Sriram K, Santha T, Prabhakar R, Somasundaram PR, Sivasubramanian S; Sriram; Santha; Prabhakar; Somasundaram; Sivasubramanian (tháng 5 năm 1999). “Short-course chemotherapy for tuberculosis of the spine. A comparison between ambulant treatment and radical surgery--ten-year report”. The Journal of Bone and Joint Surgery. British Volume 81–B (3): 464–71. PMID 10872368. [liên kết hỏng]
  21. ↑ Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM (1993). “Tuberculous Meningitis: A 30-Year Review”. Clin Infect Dis 17 (6): 987–94. PMID 8110957. doi:10.1093/clinids/17.6.987. 
  22. ↑ Teoh R, O'Mahony G, Yeung VT (1986). “Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis”. J Neurol 233 (4): 237–41. PMID 3746363. doi:10.1007/BF00314027. 
  23. ↑ Chang AB và đồng nghiệp (1998). “Central nervous system tuberculosis after resolution of miliary tuberculosis”. Pediatr Infect Dis J 17 (6): 519–23. PMID 9655548. doi:10.1097/00006454-199806000-00019. 
  24. ↑ Misra, U.K.; Kalita, J.; Nair, P.P. (2010). “Role of aspirin in tuberculous meningitis: a randomized open-label placebo-controlled trial”. J Neurol Sci 293: 12–17. doi:10.1016/j.jns.2010.03.025. 
  25. ↑ “Tuberculous meningitis: take an aspirin and call me in the morning?”. Clin Infect Dis 51 (12): iv. 2010. doi:10.1086/657238. 
  26. ↑ Purohit SD, Sarkar SK, Gupta ML, Jain DK, Gupta PR, Mehta YR (tháng 6 năm 1987). “Dietary constituents and rifampicin absorption”. Tubercle 68 (2): 151–52. PMID 3660467. doi:10.1016/0041-3879(87)90034-1. 
  27. ↑ Peloquin CA, Namdar R, Singleton MD, Nix DE (tháng 1 năm 1999). “Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids”. Chest 115 (1): 12–18. PMID 9925057. doi:10.1378/chest.115.1.12. 
  28. ↑ Siegler DI, Bryant M, Burley DM, Citron KM, Standen SM (tháng 7 năm 1974). “Effect of meals on rifampicin absorption”. Lancet 2 (7874): 197–98. PMID 4135611. doi:10.1016/S0140-6736(74)91487-1. 
  29. ↑ Peloquin CA, Namdar R, Dodge AA, Nix DE (tháng 8 năm 1999). “Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids”. The International Journal of Tuberculosis and Lung Disease 3 (8): 703–10. PMID 10460103. 
  30. ↑ Joshi MV, Saraf YS, Kshirsagar NA, Acharya VN (tháng 6 năm 1991). “Food reduces isoniazid bioavailability in normal volunteers”. The Journal of the Association of Physicians of India 39 (6): 470–71. PMID 1938852. 
  31. ↑ Zent C, Smith P (tháng 4 năm 1995). “Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide”. Tubercle and Lung Disease 76 (2): 109–13. PMID 7780091. doi:10.1016/0962-8479(95)90551-0. 
  32. ↑ Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, James GT, Nix DE (1998). “Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacids”. Pharmacotherapy 18 (6): 1205–11. PMID 9855317. doi:10.1002/j.1875-9114.1998.tb03138.x. 
  33. ↑ Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, Childs JM, Nix DE (tháng 3 năm 1999). “Pharmacokinetics of Ethambutol under Fasting Conditions, with Food, and with Antacids”. Antimicrobial Agents and Chemotherapy 43 (3): 568–72. PMC 89161. PMID 10049268. 
  34. ↑ http://www.iblogscience.com/incidence-of-extrapulmonary-tb-trending-upward-2/
  35. ↑ Gallardo, CR; Rigau Comas, D; Valderrama Rodríguez, A; Roqué I Figuls, M; Parker, LA; Caylà, J; Bonfill Cosp, X (17 tháng 5 năm 2016). “Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis.”. The Cochrane Database of Systematic Reviews 5: CD009913. PMC 4916937. PMID 27186634. doi:10.1002/14651858.CD009913.pub2. Truy cập ngày 6 tháng 6 năm 2016. 
  36. 1 2 Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D (tháng 6 năm 2003). “Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis”. American Journal of Respiratory and Critical Care Medicine 167 (11): 1472–77. PMID 12569078. doi:10.1164/rccm.200206-626OC. 
  37. 1 2 Ormerod LP, Horsfield N (tháng 2 năm 1996). “Frequency and type of reactions to antituberculosis drugs: observations in routine treatment”. Tubercle and Lung Disease 77 (1): 37–42. PMID 8733412. doi:10.1016/S0962-8479(96)90073-8. 
  38. ↑ Forget EJ, Menzies D (tháng 3 năm 2006). “Adverse reactions to first-line antituberculosis drugs”. Expert Opinion on Drug Safety 5 (2): 231–49. PMID 16503745. doi:10.1517/14740338.5.2.231. 
  39. ↑ Steele MA, Burk RF, DesPrez RM (tháng 2 năm 1991). “Toxic hepatitis with isoniazid and rifampin. A meta-analysis”. Chest 99 (2): 465–71. PMID 1824929. doi:10.1378/chest.99.2.465. 
  40. ↑ Drobac PC và đồng nghiệp (2005). “Treatment of Multidrug-Resistant Tuberculosis during Pregnancy: Long-Term Follow-Up of 6 Children with Intrauterine Exposure to Second-Line Agents”. Clin Infect Dis 40 (11): 1689–92. PMID 15889370. doi:10.1086/430066. 
  41. ↑ Palacios E, Dallman R, Muñoz M và đồng nghiệp (2009). “Drug‐resistant tuberculosis and pregnancy: Treatment outcomes of 38 cases in Lima, Peru”. Clin Infect Dis 48 (10): 1413–19. PMC 4824949. PMID 19361302. doi:10.1086/598191. 
  42. ↑ Breen RA, Miller RF, Gorsuch T và đồng nghiệp (2006). “Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy”. J Infect Dis 193 (10): 1437–40. PMID 16619192. doi:10.1086/503437. 
  43. ↑ Jenny‐Avital1 ER, Joseph K (2009). “Rifamycin‐resistant Mycobacterium tuberculosis in the highly active antiretroviral therapy era: A report of 3 relapses with acquired rifampin resistance following alternate‐day rifabutin and boosted protease inhibitor therapy”. Clin Infect Dis 48 (10): 1471–74. PMID 19368504. doi:10.1086/598336. 
  44. ↑ Cegielski JP, McMurray DN (2004). “The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals”. Int J Tubercul Lung Dis 8 (3): 286–98. 
  45. ↑ Onwubalili JK. (1988). “Malnutrition among tuberculosis patients in Harrow, England”. Eur J Clin Nutr. 42 (4): 363–66. PMID 3396528. 
  46. ↑ Karyadi E, Schultink W, Nelwan RH và đồng nghiệp (2000). “Poor Micronutrient Status of Active Pulmonary Tuberculosis Patients in Indonesia”. Journal of Nutrition 130: 2953–58. doi:10.1093/jn/130.12.2953. 
  47. ↑ Zachariah R, Spielmann MP, Harries AD, Salaniponi FM (2002). “Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death”. Trans R Soc Trop Med Hyg 96 (3): 291–94. PMID 12174782. doi:10.1016/S0035-9203(02)90103-3. 
  48. ↑ Baldwin M; Yori, PP; Ford, C; Moore, DA; Gilman, RH; Vidal, C; Ticona, E; Evans, CA (2004). “Tuberculosis and nutrition: disease perceptions and health seeking behavior of household contacts in the Peruvian Amazon”. Int J Tuberc Lung Dis 8 (12): 1484–91. PMC 2912521. PMID 15636496. 
  49. ↑ Sinclair, D; Abba, K; Grobler, L; Sudarsanam, TD (9 tháng 11 năm 2011). “Nutritional supplements for people being treated for active tuberculosis.”. The Cochrane Database of Systematic Reviews (11): CD006086. PMC 4981643. PMID 22071828. doi:10.1002/14651858.CD006086.pub3. 
  50. ↑ Nnoaham KE, Clarke A (2008). “Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis”. Int J Epidemiol 37 (1): 113–19. PMID 18245055. doi:10.1093/ije/dym247. 
  51. ↑ Davies PD (1985). “A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis”. Tubercle 66 (4): 301–06. PMID 3936248. doi:10.1016/0041-3879(85)90068-6. 
  52. ↑ Vieth R (2011). “Vitamin D nutrient to treat TB begs the prevention question”. Lancet 377 (9761): 189, 190. PMID 21215444. doi:10.1016/S0140-6736(10)62300-8. 
  53. ↑ Liu PT, Stenger S, Li H và đồng nghiệp (2006). “Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response”. Science 311 (5768): 1770–73. PMID 16497887. doi:10.1126/science.1123933. 
  54. ↑ Finsen NR (1886). Om anvendelse i medicinen af koncentrerede kemiske lysstraaler. Copenhagen, Denmark: Gyldendalske Boghandels Forlag. 
  55. ↑ Brodie MJ, Boobis AR, Hillyard CJ, Abeyasekera G, MacIntyre I, Park BK (1981). “Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity”. Clin Pharmacol Ther 30 (3): 363–67. PMID 7273600. doi:10.1038/clpt.1981.173. 
  56. ↑ Brodie MJ, Boobis AR, Hillyard CJ và đồng nghiệp (1982). “Effect of rifampicin and isoniazid on vitamin D metabolism”. Clin Pharmacol Ther 32 (4): 525–30. PMID 7116768. doi:10.1038/clpt.1982.197. 
  57. ↑ Perry W, Erooga MA, Brown J, Stamp TC (1982). “Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis”. J R Soc Med 75 (7): 533–36. PMC 1437875. PMID 7086805. 
  58. ↑ Williams SE, Wardman AG, Taylor GA, Peacock M, Cooke NJ (1985). “Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism”. Tubercle 66 (1): 49–54. PMID 3838603. doi:10.1016/0041-3879(85)90053-4. 
  59. ↑ Chan TY (1996). “Osteomalacia during rifampicin and isoniazid therapy is rare in Hong Kong”. Int J Clin Pharmacol Ther 34 (12): 533–34. PMID 8996847. 
  60. ↑ Bellamy R, Ruwende C, Corrah T và đồng nghiệp (1998). “Tuberculosis and chronic hepatitis B virus infection in africans and variation in the vitamin D receptor gene”. J Infect Dis 179 (3): 721–24. PMID 9952386. doi:10.1086/314614. 
  61. ↑ Wilkinson R, Llewelyn M, Toossi Z và đồng nghiệp (2000). “Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study”. Lancet 355 (9204): 618–21. PMID 10696983. doi:10.1016/S0140-6736(99)02301-6. 
  62. ↑ 刘玮,张翠英,吴晓明 và đồng nghiệp (2003). “维生素D受体基因多态性与肺结核易感性的病例对照研究 (A case-control study on the vitamin D receptor gene polymorphisms and susceptibility to pulmonary tuberclosis)”. 中华流行病学杂志 (Chinese Journal of Epidemiology) (bằng tiếng Chinese) 24 (5): 389–92. PMID 12820934.  Bảo trì CS1: Ngôn ngữ không rõ (link)
  63. ↑ Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). “Weekly Rifapentine/Isoniazid or Daily Rifampin/Pyrazinamide for Latent Tuberculosis in Household Contacts”. Am J Respir Crit Care Med 173 (8): 922–26. PMC 2662911. PMID 16474028. doi:10.1164/rccm.200512-1953OC. 
  64. ↑ Ijaz K, Jereb JA, Lambert LA và đồng nghiệp (2006). “Severe of fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis”. Clin Infect Dis 42 (3): 346–55. PMID 16392079. doi:10.1086/499244. 
  65. ↑ Smieja M. J.; Marchetti C. A.; Cook D. J.; Smaill F. M. (2000). “Isoniazid for preventing tuberculosis in non-HIV infected persons”. Cochrane Database of Systematic Reviews 2: CD001363. PMID 10796642. doi:10.1002/14651858.CD001363. 
  66. ↑ Sharma SK, Sharma A, Kadhiravan T, Tharyan P (2013). “Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB”. Cochrane Database Syst Rev 7: CD007545. PMID 23828580. doi:10.1002/14651858.CD007545.pub2. 
  67. ↑ Stagg HR, Zenner D, Harris RJ, Muñoz L, Lipman MC, Abubakar I (tháng 8 năm 2014). “Treatment of Latent Tuberculosis Infection: A Network Meta-analysis”. Ann. Intern. Med. 161 (6): 419–28. PMID 25111745. doi:10.7326/M14-1019. 
  68. ↑ World Health Organisation. “WHO Global Task Force outlines measures to combat XDR-TB worldwide”. Truy cập ngày 21 tháng 10 năm 2006. 
  69. 1 2 Centers for Disease Control and Prevention (2006). “Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs — Worldwide, 2000–2004”. MMWR Weekly 55 (11): 301–05. 
  70. 1 2 Sarah McGregor. “New TB strain could fuel South Africa AIDS toll”. Reuters. Truy cập ngày 17 tháng 9 năm 2006. [liên kết hỏng]
  71. ↑ Frieden TR, Sterling T, Pablos-Mendez A và đồng nghiệp (1993). “The emergence of drug-resistant tuberculosis in New York City”. N Engl J Med 328 (8): 521–56. PMID 8381207. doi:10.1056/NEJM199302253280801. 
  72. ↑ Laurie Garrett (2000). Betrayal of trust: the collapse of global public health. New York: Hyperion. tr. 268ff. ISBN 9780786884407. 
  73. ↑ Farmer Paul (2001). “The Major Infectious Diseases in the World -- To Treat or Not to Treat?”. N Engl J Med 345 (3): 208–210. PMID 11463018. doi:10.1056/nejm200107193450310. 
  74. ↑ Salazar-Austin N, Ordonez AA, Hsu AJ và đồng nghiệp (2015). “Extensively drug-resistant tuberculosis in a young child after travel to India”. The Lancet Infectious Diseases 15 (12): 1485–1491. PMC 4843989. PMID 26607130. doi:10.1016/S1473-3099(15)00356-4. 
  75. ↑ Shah NS, Wright A, Drobniewski F và đồng nghiệp (2005). “Extreme drug resistance in tuberculosis (XDR-TB): global survey of supranational reference laboratories for _Mycobacterium tuberculosis_ with resistance to second-line drugs”. Int J Tuberc Lung Dis. 9 (Suppl 1): S77. 
  76. ↑ Centers for Disease Control and Prevention (2006). “Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs — Worldwide, 2000–2004”. MMWR Weekly 55 (11): 301–05. 
  77. ↑ Gandhi NR, Moll A, Sturm AW và đồng nghiệp (2006). “Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa”. Lancet 368 (9547): 1575–80. PMID 17084757. doi:10.1016/S0140-6736(06)69573-1. 
  78. ↑ Angela Quintal. “314 XDR-TB cases reported in SA”. Cape Times. Truy cập ngày 4 tháng 4 năm 2007. [liên kết hỏng]
  79. ↑ Migliori GB, Ortmann J, Girardi E và đồng nghiệp (2007). “Extensively Drug-resistant Tuberculosis, Italy and Germany”. Emerging Infectious Diseases 13 (5): 780–82. PMC 2738462. PMID 18044040. doi:10.3201/eid1305.070200. 
  80. ↑ Sidley P. (2006). “South Africa acts to curb spread of lethal strain of TB”. Br Med J 333 (7573): 825. PMC 1618468. PMID 17053232. doi:10.1136/bmj.333.7573.825-a. 
  81. ↑ News24. “300+ cases of killer TB in SA”. Bản gốc lưu trữ ngày 1 tháng 10 năm 2007. Truy cập ngày 23 tháng 11 năm 2006. 
  82. ↑ Singh JA, Upshur R, Padayatchi N (2007). “XDR-TB in South Africa: No Time for Denial or Complacency”. PLoS Med 4 (1): e50. PMC 1779818. PMID 17253901. doi:10.1371/journal.pmed.0040050. 
  83. ↑ Orenstein EW, Basu S, Shah NS và đồng nghiệp (2009). “Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis”. Lancet Infect Dis 9 (3): 153–61. PMID 19246019. doi:10.1016/S1473-3099(09)70041-6. 
  84. ↑ Mitnick C và đồng nghiệp (2003). “Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru”. N Engl J Med 348 (2): 119–28. PMID 12519922. doi:10.1056/NEJMoa022928. 
  85. ↑ Gillespie SH (2002). “Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective”. Antimicrob Agents Chemother 46 (2): 267–74. PMC 127054. PMID 11796329. doi:10.1128/AAC.46.2.267-274.2002. 
  86. ↑ Bang D, Andersen ÅB, Thomsen VØ (2006). “Rapid Genotypic Detection of Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis Directly in Clinical Specimens”. J Clin Microbiol 44 (7): 2605–08. PMC 1489488. PMID 16825393. doi:10.1128/JCM.00752-06. 
  87. ↑ Aktas E, Durmaz R, Yang D, Yang Z (2005). “Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey”. Microbial Drug Resistance 11 (2): 94–99. PMID 15910221. doi:10.1089/mdr.2005.11.94. 
  88. ↑ Steering Group; Ernesto Jaramillo... (2008). Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008 (WHO/HTM/TB/2008.402). Geneva, Switzerland: World Health Organization. tr. 51. ISBN 9789241547581. 
  89. ↑ Reljic R (2007). “IFN-gamma therapy of tuberculosis and related infections”. J Interferon Cytokine Res 27 (5): 353–64. PMID 17523867. doi:10.1089/jir.2006.0103. 
  90. ↑ “Old drug combination in TB fight”. BBC News. 27 tháng 2 năm 2009. Truy cập ngày 27 tháng 2 năm 2009. 
  91. ↑ Dauby N, Muylle I, Mouchet F, Sergysels R, Payen MC (2011). “Meropenem/Clavulanate and Linezolid Treatment for Extensively Drug-Resistant Tuberculosis”. Pediatric Infectious Disease Journal 30 (9): 812–3. PMID 21378593. doi:10.1097/INF.0b013e3182154b05. 
  92. ↑ Ziganshina, Lilia E; Squire, Stephen B (2008). “Fluoroquinolones for treating tuberculosis”. Cochrane Database of Systematic Reviews (1): CD004795. PMID 18254061. doi:10.1002/14651858.CD004795.pub3. 
  93. ↑ Leimane V và đồng nghiệp (2005). “Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study”. Lancet 365 (9456): 318–26. PMID 15664227. doi:10.1016/S0140-6736(05)17786-1. 
  94. ↑ Schön T, Elias D, Moges F và đồng nghiệp (2003). “Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis”. Eur Respir J 21 (3): 483–88. PMID 12662006. doi:10.1183/09031936.03.00090702. 
  95. ↑ Rockett KA, Brookes R, Udalova I và đồng nghiệp (1 tháng 11 năm 1998). “1,25-Dihydroxyvitamin D3 Induces Nitric Oxide Synthase and Suppresses Growth of Mycobacterium tuberculosis in a Human Macrophage-Like Cell Line”. Infection and Immunity 66 (11): 5314–21. PMC 108664. PMID 9784538. 
  96. ↑ Chambers HF, Turner J, Schecter GF, Kawamura M, Hopewell PC (2005). “Imipenem for Treatment of Tuberculosis in Mice and Humans”. Antimicrob Agents Chemother 49 (7): 2816–21. PMC 1168716. PMID 15980354. doi:10.1128/AAC.49.7.2816-2821.2005. 
  97. ↑ Chambers HF, Kocagoz T, Sipit T, Turner J, Hopewell PC (1998). “Activity of amoxicillin/clavulanate in patients with tuberculosis”. Clin Infect Dis 26 (4): 874–77. PMID 9564467. doi:10.1086/513945. 
  98. ↑ Donald PR, Sirgel FA, Venter A và đồng nghiệp (2001). “Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosis”. Scand J Infect Dis 33 (6): 466–69. PMID 11450868. doi:10.1080/00365540152029954. 
  99. ↑ Jagannath C, Reddy MV, Kailasam S, O'Sullivan JF, Gangadharam PR (1 tháng 4 năm 1995). “Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies”. Am J Respir Crit Care Med 151 (4): 1083–86. PMID 7697235. doi:10.1164/ajrccm.151.4.7697235. 
  100. ↑ Adams LM, Sinha I, Franzblau SG và đồng nghiệp (1999). “Effective Treatment of Acute and Chronic Murine Tuberculosis with Liposome-Encapsulated Clofazimine” (PDF). Antimicrob Agents Chemother 43 (7): 1638–43. PMC 89336. PMID 10390215. 
  101. ↑ Janulionis, E.; Sofer, C; Song, HY; Wallis, RS (2004). “Lack of Activity of Orally Administered Clofazimine against Intracellular Mycobacterium tuberculosis in Whole-Blood Culture” (PDF). Antimicrob Agents Chemother 48 (8): 3133–35. PMC 478499. PMID 15273133. doi:10.1128/AAC.48.8.3133-3135.2004. 
  102. ↑ Shubin H; Sherson J; Pennes E; Glaskin A; Sokmensuer A. (1958). “Prochlorperazine (compazine) as an aid in the treatment of pulmonary tuberculosis”. Antibiotic Med Clin Ther. 5 (5): 305–09. PMID 13521769. 
  103. ↑ Wayne LG, Sramek HA (1994). “Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis”. Antimicrob Agents Chemother 38 (9): 2054–58. PMC 284683. PMID 7811018. doi:10.1128/AAC.38.9.2054. 
  104. ↑ “FDA Press Release”. U.S. Food and Drug Administration. 31 tháng 12 năm 2012. 
  105. ↑ Carroll, John (31 tháng 12 năm 2012). “J&J wins accelerated OK for first new TB drug in 40 years”. fiercebiotech.com. Truy cập ngày 3 tháng 1 năm 2013. 
  106. ↑ Stover CK, Warrener P, VanDevanter DR và đồng nghiệp (2000). “A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis”. Nature 405 (6789): 962–66. PMID 10879539. doi:10.1038/35016103. 
  107. ↑ Chase, Marilyn (27 tháng 10 năm 2004). “Novartis Sets Deal to Seek New Drugs for Fighting TB”. The Wall Street Journal. Bản gốc lưu trữ ngày 6 tháng 5 năm 2007. Truy cập ngày 3 tháng 1 năm 2013. 
  108. ↑ name="MRC1948">“Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation”. British Medical Journal 2 (4582): 769–82. Tháng 10 năm 1948. PMC 2091872. PMID 18890300. doi:10.1136/bmj.2.4582.769. 
  109. 1 2 Wang JY, Hsueh PR, Jan IS và đồng nghiệp (tháng 10 năm 2006). “Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas”. Thorax 61 (10): 903–08. PMC 2104756. PMID 16809417. doi:10.1136/thx.2005.056887. 
  110. ↑ “Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation”. British Medical Journal 2 (4582): 769–82. Tháng 10 năm 1948. PMC 2091872. PMID 18890300. doi:10.1136/bmj.2.4582.769. 
  111. ↑ World Health Organization. “Global tuberculosis control–surveillance, planning, financing WHO Report 2006”. Truy cập ngày 13 tháng 10 năm 2006. 
  112. ↑ Chaisson, RE; Martinson, NA (13 tháng 3 năm 2008). “Tuberculosis in Africa--combating an HIV-driven crisis”. The New England Journal of Medicine 358 (11): 1089–92. PMID 18337598. doi:10.1056/NEJMp0800809. 
  113. ↑ Davies PD, Yew WW, Ganguly D, Davidow AL, Reichman LB, Dheda K, Rook GA (tháng 4 năm 2006). “Smoking and tuberculosis: the epidemiological association and immunopathogenesis.”. Transactions of the Royal Society of Tropical Medicine and Hygiene 100 (4): 291–8. PMID 16325875. doi:10.1016/j.trstmh.2005.06.034. 
  114. 1 2 3 ATS/CDC Statement Committee on Latent Tuberculosis Infection (tháng 6 năm 2000). “Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society”. MMWR Recomm Rep 49 (RR–6): 1–51. PMID 10881762. 
  115. ↑ Restrepo, BI (15 tháng 8 năm 2007). “Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances.”. Clinical Infectious Diseases 45 (4): 436–8. PMC 2900315. PMID 17638190. doi:10.1086/519939. 
  116. ↑ Möller, M; Hoal, EG (tháng 3 năm 2010). “Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis.”. Tuberculosis (Edinburgh, Scotland) 90 (2): 71–83. PMID 20206579. doi:10.1016/j.tube.2010.02.002. 
  117. ↑ Lee JH (1948). “Tuberculosis and Silicosis”. Can Med Assoc J 58 (4): 349–353. PMC 1591092. PMID 18916106. 
  118. ↑ Varkey B (26 tháng 1 năm 2011). “Silicosis”. WebMD. Truy cập ngày 26 tháng 7 năm 2011. 
  119. ↑ Segall L, Covic A (tháng 6 năm 2010). “Diagnosis of tuberculosis in dialysis patients: current strategy”. Clin J Am Soc Nephrol 5 (6): 1114–22. PMID 20413440. doi:10.2215/CJN.09231209. 
  120. ↑ “NIOSH – Silicosis: Learn the Facts!”. cdc.gov. Truy cập ngày 13 tháng 4 năm 2010. 
  121. 1 2 Mutlu G, Mutlu E, Bellmeyer A, Rubinstein I (2006). “Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy”. Am J Med 119 (8): 639–46. PMID 16887405. doi:10.1016/j.amjmed.2006.01.015. 
  122. ↑ Leung CC (tháng 6 năm 2007). “Lower risk of tuberculosis in obesity”. Arch. Intern. Med. 167 (12): 1297–304. PMID 17592104. doi:10.1001/archinte.167.12.1297. Bản gốc lưu trữ ngày 15 tháng 2 năm 2009. Figures OI70054T5, OI70054F1 
  123. ↑ Restrepo, BI (2007). “Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances”. Clin Infect Dis 45 (4): 436–8. PMC 2900315. PMID 17638190. doi:10.1086/519939. 
  124. ↑ Nijland HMJ và đồng nghiệp (2006). “Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes”. Clin Infect Dis 43 (7): 848–854. PMID 16941365. doi:10.1086/507543. 
  125. 1 2 Strachan DP, Powell KJ, Thaker A, Millard FJ, Maxwell JD (tháng 2 năm 1995). “Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians”. Thorax 50 (2): 175–80. PMC 473919. PMID 7701458. doi:10.1136/thx.50.2.175. 
  126. ↑ Davis L (1995). “Vegetarian diet and tuberculosis in immigrant Asians”. Thorax 50 (8): 915–6. PMC 474924. PMID 7570453. doi:10.1136/thx.50.8.915-c. 
  127. ↑ Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN (2005). “Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London”. J Infect 50 (5): 432–7. PMID 15907552. doi:10.1016/j.jinf.2004.07.006. 
  128. ↑ Nnoaham KE, Clarke A (2008). “Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis”. Int J Epidemiol 37 (1): 113–9. PMID 18245055. doi:10.1093/ije/dym247. 
  129. ↑ Schaible UE, Kaufmann SH (2007). “Malnutrition and Infection: Complex Mechanisms and Global Impacts”. PLOS Medicine 4 (5): e115. PMC 1858706. PMID 17472433. doi:10.1371/journal.pmed.0040115. 
  130. ↑ Lönnroth K, Raviglione M (2008). “Global epidemiology of tuberculosis: prospects for control”. Seminars in respiratory and critical care medicine 29 (5): 481–91. PMID 18810682. doi:10.1055/s-0028-1085700. 
  131. ↑ Davies PD (2003). “The world-wide increase in tuberculosis: how demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis”. Annals of Medicine 35 (4): 235–43. PMID 12846265. doi:10.1080/07853890310005713. 
  132. ↑ Spence DP, Hotchkiss J, Williams CS, Davies PD (1993). “Tuberculosis and poverty”. BMJ (Clinical research ed.) 307 (6907): 759–61. PMC 1696420. PMID 8219945. doi:10.1136/bmj.307.6907.759. 
  133. ↑ “Increased US Prison Population Has Profound Demographic Consequences, Disproportionately Affecting Black Males”. Medicalnewstoday.com. Truy cập ngày 24 tháng 10 năm 2011. 
  134. ↑ “Tuberculosis: stopping a killer that can't be kept behind bars”. ICRC. Truy cập ngày 26 tháng 7 năm 2011. 
  135. ↑ Larouzé B, Sánchez A, Diuana V (2008). “Tuberculosis behind bars in developing countries: a hidden shame to public health”. Trans. R. Soc. Trop. Med. Hyg. 102 (9): 841–2. PMID 18513772. doi:10.1016/j.trstmh.2008.04.020. 
  136. ↑ Nnoaham KE, Clarke A (2008). “Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis”. Int J Epidemiol 37 (1): 113–19. PMID 18245055. doi:10.1093/ije/dym247. 
  137. ↑ Farmer, Paul (tháng 6 năm 2004). “An Anthropology of Structural Violence” (PDF). Current Anthropology 45 (4): 305–325. doi:10.1086/382250. Truy cập ngày 15 tháng 4 năm 2014. 
  138. ↑ Farmer, Paul (2004). Pathologies of Power. London: University of California Press. tr. 40–42. ISBN 0520931475. 

Tài liệu tham khảo

WikiPedia: Quản lý bệnh lao http://linkinghub.elsevier.com/retrieve/pii/S01406... http://linkinghub.elsevier.com/retrieve/pii/S0163-... http://erj.ersjournals.com/cgi/content/abstract/21... http://www.fiercebiotech.com/story/jj-wins-acceler... http://www.iblogscience.com/incidence-of-extrapulm... http://openurl.ingenta.com/content/nlm?genre=artic... http://openurl.ingenta.com/content/nlm?genre=artic... http://www.medicalnewstoday.com/releases/117049.ph... http://emedicine.medscape.com/article/302027-overv... http://www.news24.com/News24/South_Africa/News/0,,...